291 related articles for article (PubMed ID: 25742748)
21. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ
J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017
[TBL] [Abstract][Full Text] [Related]
22. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
[TBL] [Abstract][Full Text] [Related]
23. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
24. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
[TBL] [Abstract][Full Text] [Related]
25. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.
Pulikkan JA; Hegde M; Ahmad HM; Belaghzal H; Illendula A; Yu J; O'Hagan K; Ou J; Muller-Tidow C; Wolfe SA; Zhu LJ; Dekker J; Bushweller JH; Castilla LH
Cell; 2018 Jun; 174(1):172-186.e21. PubMed ID: 29958106
[TBL] [Abstract][Full Text] [Related]
26. CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus.
Zhao L; Cannons JL; Anderson S; Kirby M; Xu L; Castilla LH; Schwartzberg PL; Bosselut R; Liu PP
Blood; 2007 Apr; 109(8):3432-40. PubMed ID: 17185462
[TBL] [Abstract][Full Text] [Related]
27. CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML.
Liu P; Liu JP; Sun SJ; Gao Y; Ai Y; Chen X; Sun Y; Zhou M; Liu Y; Xiong Y; Yuan HX
Front Cell Dev Biol; 2021; 9():675424. PubMed ID: 34336831
[TBL] [Abstract][Full Text] [Related]
28. Cbfbeta reduces Cbfbeta-SMMHC-associated acute myeloid leukemia in mice.
Heilman SA; Kuo YH; Goudswaard CS; Valk PJ; Castilla LH
Cancer Res; 2006 Dec; 66(23):11214-8. PubMed ID: 17145866
[TBL] [Abstract][Full Text] [Related]
29. Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability.
Wunderlich M; Krejci O; Wei J; Mulloy JC
Blood; 2006 Sep; 108(5):1690-7. PubMed ID: 16670269
[TBL] [Abstract][Full Text] [Related]
30. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
Kuo YH; Zaidi SK; Gornostaeva S; Komori T; Stein GS; Castilla LH
Blood; 2009 Apr; 113(14):3323-32. PubMed ID: 19179305
[TBL] [Abstract][Full Text] [Related]
31. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
[TBL] [Abstract][Full Text] [Related]
33. Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).
Markus J; Garin MT; Bies J; Galili N; Raza A; Thirman MJ; Le Beau MM; Rowley JD; Liu PP; Wolff L
Cancer Res; 2007 Feb; 67(3):992-1000. PubMed ID: 17283131
[TBL] [Abstract][Full Text] [Related]
34. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
35. NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis.
Xue L; Pulikkan JA; Valk PJ; Castilla LH
Blood; 2014 Jul; 124(3):426-36. PubMed ID: 24894773
[TBL] [Abstract][Full Text] [Related]
36. The core binding factor CBF negatively regulates skeletal muscle terminal differentiation.
Philipot O; Joliot V; Ait-Mohamed O; Pellentz C; Robin P; Fritsch L; Ait-Si-Ali S
PLoS One; 2010 Feb; 5(2):e9425. PubMed ID: 20195544
[TBL] [Abstract][Full Text] [Related]
37. Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.
Castilla LH; Perrat P; Martinez NJ; Landrette SF; Keys R; Oikemus S; Flanegan J; Heilman S; Garrett L; Dutra A; Anderson S; Pihan GA; Wolff L; Liu PP
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4924-9. PubMed ID: 15044690
[TBL] [Abstract][Full Text] [Related]
38. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.
Castilla LH; Wijmenga C; Wang Q; Stacy T; Speck NA; Eckhaus M; Marín-Padilla M; Collins FS; Wynshaw-Boris A; Liu PP
Cell; 1996 Nov; 87(4):687-96. PubMed ID: 8929537
[TBL] [Abstract][Full Text] [Related]
39. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.
Satpathy AT; Briseño CG; Cai X; Michael DG; Chou C; Hsiung S; Bhattacharya D; Speck NA; Egawa T
Blood; 2014 May; 123(19):2968-77. PubMed ID: 24677539
[TBL] [Abstract][Full Text] [Related]
40. RUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1).
Hyde RK; Liu PP
J Cell Biochem; 2010 Aug; 110(5):1039-45. PubMed ID: 20589720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]